Atención farmacéutica a pacientes hospitalizados. Repercusión clinica y económica

• Autores: M. A. González Fernández, Jesús Llorente Gutiérrez, M. Ruano Encinar, E. Jiménez-Caballero
• Localización: Atención Farmacéutica, ISSN 1139-7357, Vol. 4, Nº. 6, 2002, págs. 384-396
• Idioma: español
• Títulos paralelos:
  • Pharmaceutical care for hospitalized patients. Clinical and economic repercussion
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objective: To evaluate the results from a clinical and economic point of view on the establishment of a pharmaceutical care program by means of pharmaceutical interventions done mainly at the clinical unit. Material and methods: Every pharmacist is responsible for approximately 100 beds and, on a daily basis, attends the corresponding clinical department. It was designed a «data-gathering sheet» in order to facilitate the obtaining process and, afterwards, it was elaborated a database in which the interventions taken place over eight months were entered, and it was proceeded to their exploitation and interpretation. Results: There have taken place 436 pharmaceutical interventions with a 97.25% of acceptance (the drugs not included in the Guidebook or DNIG are not included) directed in a 51.61% towards surgical services and the rest towards medical services. The most-frequently involved drugs were anti-infectious (47.25%) and antiulcerous (16.74%) ones. The most frequent interventions corresponded to an incorrect dosage (31.19%) and to an incorrect association (11.01%) and the most frequent results of such interventions were a change in the posologic regime (41.19%) and a drug suspension (22.2%). From a clinical impact point of view, 52.33% of interventions improved efficiency, 25.55% either decreased or avoided toxicity and 22.11 % increased efficacy. In this study, the final generated savings, by integrating both the saved cost (12,984 ?) and the avoided cost (46,352 ?), have been of 59,337 ? (9,872,859 PTA). Conclusion: It has been shown the necessity of the pharmacist's presence at the clinical units in obtaining a significant decrease in treatment morbility as well as an improvement on treatment efficacy; in addition to considerable savings for the hospital translated into a decrease in days of stay